## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `carpal-tunnel-syndrome`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `carpal-tunnel-syndrome` v4 · content_hash `a702c37807b446a9…` · thread_head genesis
- **thesis (c1):** Surgery versus starting with a corticosteroid injection has been settled by randomised trial rather than left to preference.
  - c2 [rct/active] Cochrane review evidence, not opinion, sets the comparison between surgical and non-surgical management for this condition.
  - c3 [rct/active] Splinting the wrist together with the metacarpophalangeal joints has been tested separately from wrist-only splinting, and the joints included change the result
  - c4 [expert/active] The diagnosis should be confirmed before choosing between treatments, because the treatment evidence applies to confirmed carpal tunnel syndrome and not to wris
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `carpal-tunnel-syndrome`
- **title:** Carpal tunnel syndrome: the median nerve in a passage that cannot expand
- **url:** https://miscsubjects.com/a/carpal-tunnel-syndrome
- **register:** accessible
- **updated:** 2026-08-05T09:18:29.085Z

## Body

The tell is which fingers. The median nerve serves your thumb, index finger, middle finger, and the thumb-side half of your ring finger — and nothing else. If your little finger is numb too, the problem is probably not at the carpal tunnel, because that finger is fed by a different nerve entirely. Split your ring finger down the middle in your imagination: numbness on the thumb side and normal sensation on the little-finger side is close to a signature.

The second tell is the clock. This wakes people at two in the morning, and they shake the hand over the side of the bed until it settles. Wrists drift into a bent position during sleep, which is the position that squeezes the tunnel hardest.

What is happening is mechanical. The median nerve runs through a passage in the wrist floored by bone and roofed by a stiff ligament. The passage cannot expand. Anything that takes up room inside it — thickened tendon sheaths, fluid, swelling — presses the nerve against the roof.

## The question everyone asks, and the trial that finally answered it

For years the honest answer to "surgery or an injection?" was that nobody knew. The Cochrane review published in 2024 looked at what existed and could not separate them: for clinical improvement beyond three months, its verdict on surgery versus corticosteroid injection was very low certainty.

[[embed:source:s1]]

Then a trial large enough to settle it reported. DISTRICTS randomised 934 people across 31 hospitals in the Netherlands to start with surgery or start with an injection, and followed them for eighteen months.

[[embed:source:s2]]

**At eighteen months, 61% of the surgery group had recovered against 45% of the injection group.**

[[embed:source:s3]]

That is a real difference and it points one way. Note the framing, though — the trial compared *starting with* one or the other, and people in either arm could go on to have more treatment. It is a comparison of opening moves, not of a permanent fork.

## What splinting does, and the number that decides it

Against splinting, the Cochrane picture is more interesting than "surgery wins".

Surgery produced a higher rate of clinical improvement, on moderate-certainty evidence. But on the actual symptom and function scores, the difference between surgery and a splint did not reach the level considered clinically important. In other words, more people in the surgery group crossed the line marked "improved", while the average person's symptoms and hand function were not meaningfully further apart.

The number that resolves the tension is this one: **44 of every 100 people in the splinting groups ended up referred for surgery anyway.**

[[embed:source:s4]]

So splinting is not a lesser version of surgery. It is a filter. Just over half the people who try it do not go on to need an operation, and the other 44% arrive at surgery later than they would have — having avoided nothing except time.

The cost side is real too. Adverse effects were reported in 61% of the surgery participants and 41% of the splinting participants, though the review is explicit that it is uncertain about this comparison.

## If you are going to splint, splint the right joints

The standard wrist splint may not be the best version of the idea. A randomised trial compared the usual wrist-only splint against one that also holds the knuckles. The splint including the knuckles did better, and the advantage was still there six months later.

[[embed:source:s5]]

It also produced better pinch strength, which is the function people actually miss — opening packets, holding a key, doing up buttons.

## The honest decision framework, written by people with no product to sell

The Cochrane authors did something unusual and wrote down who each route suits. It is worth reading as written, because it does not pretend the evidence picks for you.

[[embed:source:s6]]

Read against DISTRICTS, the two fit together. If your symptoms are severe and you want the highest chance of being recovered in a year and a half, starting with surgery is the better opening move. If your symptoms are tolerable and you have not tried anything yet, starting conservatively costs you a 44% chance of arriving at surgery later — and buys a better-than-even chance of never needing it.

## What an updated review adds, and what it takes away

A 2026 systematic review reached the same shape of conclusion — durable recovery from surgery, short-term relief from injections and nerve stimulation — and then said something that belongs on this page more than its conclusion does.

[[embed:source:s7]]

Limited trials, and most of them at risk of bias. That is the state of the field outside of DISTRICTS, and it is why one large well-run trial changed the answer so much.

## Get the diagnosis confirmed before you choose anything

DISTRICTS did not enrol people on symptoms alone: every participant had the diagnosis confirmed by nerve testing or ultrasound. That matters when you are deciding whether its 61% applies to you, because several conditions imitate this one — a nerve pinched in the neck, a more general nerve problem, arthritis at the base of the thumb. If the little finger is involved, or both hands and both feet are involved, the tunnel is probably not the whole story.

## Ten people with carpal tunnel syndrome

Ten people have confirmed carpal tunnel syndrome and start with a corticosteroid injection. At eighteen months, between four and five of them are recovered. Ten others start with surgery: about six are recovered. Of ten who start with a splint, four to five end up referred for surgery anyway, and the rest do not. More of the operated group report an adverse effect, and the review is candid that it is not certain by how much.

Nobody can tell you in advance which of those you would have been. What the numbers do is set the price of waiting: it is not zero, and it is not disastrous.

## The volume problem no compound addresses

No repair peptide has randomised human trial evidence in carpal tunnel syndrome. There is no result to summarise. This is a compression problem in a passage that cannot expand — the constraint is architectural, and any argument that a compound helps has to explain how it changes the volume inside a fixed tunnel. That argument, where it exists at all, belongs on a page naming both the compound and this condition, with its evidence tier attached. The operator of this site has a commercial interest in compounds of that kind, which is why this page states the absence rather than building a case.

## Choosing your opening move

1. **Check the fingers.** Thumb, index, middle, and the thumb side of the ring finger. Little finger involvement points somewhere else.
2. **Get it confirmed by nerve testing or ultrasound.** The good evidence comes from trials that only enrolled confirmed cases.
3. **If you splint, use one that includes the knuckles.** It beat the wrist-only splint and the advantage lasted six months.
4. **Know the price of starting conservatively.** Roughly 44 in 100 end up referred for surgery anyway. That is the cost of the option, and for most people it is worth paying.
5. **If your symptoms are severe and you want the best odds at eighteen months, start with surgery.** 61% against 45% in the largest trial available.
6. **Fix the night position.** The bent wrist during sleep is what wakes you, and a splint worn only at night addresses the specific thing that is happening.


## Claims (4)

- **c1** [rct w=?] Surgery versus starting with a corticosteroid injection has been settled by randomised trial rather than left to preference.
  - who_claims: webhook
  - sources: s2, s3
- **c2** [rct w=?] Cochrane review evidence, not opinion, sets the comparison between surgical and non-surgical management for this condition.
  - who_claims: webhook
  - sources: s1, s4, s6, s7
- **c3** [rct w=?] Splinting the wrist together with the metacarpophalangeal joints has been tested separately from wrist-only splinting, and the joints included change the result.
  - who_claims: webhook
  - sources: s5
- **c4** [expert w=?] The diagnosis should be confirmed before choosing between treatments, because the treatment evidence applies to confirmed carpal tunnel syndrome and not to wrist pain in general.
  - who_claims: webhook
  - sources: s1, s7

## Voxel graph (4 atoms · 13 edges)
- full graph: https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (7)
- chain valid: yes · head: `a4bfa77104d259da`

### s1 · pubmed
- title: Surgical versus non-surgical treatment for carpal tunnel syndrome
- url: https://pubmed.ncbi.nlm.nih.gov/38189479/
- summary: Cochrane 2024: on the evidence available at the time, surgery versus corticosteroid injection beyond three months could not be separated — very low certainty.
- quote: 2) Surgery compared to corticosteroid injection in the long term (> 3 months) We are uncertain if clinical improvement or symptom relief differs between surgery and corticosteroid injection (very low-certainty evidence).
- hash: `d4a27e5b595cd035`

### s2 · pubmed
- title: Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial
- url: https://pubmed.ncbi.nlm.nih.gov/40517008/
- summary: DISTRICTS, Lancet 2025: 934 participants across 31 Dutch hospitals, every one with the diagnosis confirmed by nerve testing or ultrasound, randomised to start with surgery or with an injection and followed for 18 months.
- quote: This study aimed to compare starting treatment with surgery versus starting with a corticosteroid injection.MethodsWe conducted an open-label, randomised controlled trial across 31 hospitals in the Netherlands.
- hash: `47a4a60cf0317529`

### s3 · pubmed
- title: [Should carpal tunnel syndrome treatment start with surgery or an injection?]
- url: https://pubmed.ncbi.nlm.nih.gov/41569103/
- summary: The DISTRICTS result stated plainly: at 18 months, 61% recovered after starting with surgery against 45% after starting with an injection. Recovery was defined as scoring under eight points on the six-item carpal tunnel scale.
- quote: The recovery rate in the surgery group was 61% and significantly higher than the 45% recovery rate in the injection group.
- hash: `8817a082678f5818`

### s4 · pubmed
- title: Surgical versus non-surgical treatment for carpal tunnel syndrome
- url: https://pubmed.ncbi.nlm.nih.gov/38189479/
- summary: Cochrane 2024: the number that decides whether splinting is worth starting with — 44 of every 100 people who splint are referred for surgery anyway, which also means the majority are not.
- quote: Surgery probably reduces the risk of further surgery; 41 of 93 participants (44%) were referred to surgery in the splinting group and 0 of 83 participants (0%) repeated surgery in the surgery group (RR 0.03, 95% CI 0.00 to 0.21; 2 studies, 176 participants).
- hash: `afe58317ed4a6eb7`

### s5 · pubmed
- title: Efficacy of splinting the wrist and metacarpophalangeal joints for the treatment of Carpal tunnel syndrome: an assessor-blinded randomised controlled trial
- url: https://pubmed.ncbi.nlm.nih.gov/38016794/
- summary: BMJ Open 2023: a splint that also holds the knuckles beat the standard wrist-only splint, with the advantage still present at six months and better pinch strength — the function people actually miss.
- quote: A wrist splint that incorporates the MCP joints is more effective than the traditional wrist-only splint, with long-lasting improvements that remained consistent after 6 months of the splint intervention.
- hash: `4a35bc7d9c6bf9e4`

### s6 · pubmed
- title: Surgical versus non-surgical treatment for carpal tunnel syndrome
- url: https://pubmed.ncbi.nlm.nih.gov/38189479/
- summary: Cochrane 2024 wrote down who each route suits rather than pretending the evidence chooses for the reader. The companion sentence says those with tolerable symptoms who have tried nothing yet can start conservatively and operate only if needed.
- quote: Patients with severe symptoms, a high preference for clinical improvement and reluctance to adhere to non-surgical options, and who do not consider potential surgical risks and morbidity a burden, may choose surgery.
- hash: `ad9607c77922a77b`

### s7 · pubmed
- title: Surgical Versus Conservative Management for Carpal Tunnel Syndrome: An Updated Systematic Review of Randomised Trials
- url: https://pubmed.ncbi.nlm.nih.gov/42041808/
- summary: Brain Sciences 2026: an updated review agreeing that surgery is more durable and injections useful short-term, and stating the condition of the field around it — few trials, most at risk of bias.
- quote: These findings should be interpreted with caution given the limited number of trials and the risk of bias in most included studies.
- hash: `a4bfa77104d259da`

## Provenance (0 model passes)
- chain valid: yes · head: `genesis`


## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"carpal-tunnel-syndrome","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest carpal-tunnel-syndrome|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim carpal-tunnel-syndrome|tier|assertion`
- **iMessage ask:** `carpal-tunnel-syndrome|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `carpal-tunnel-syndrome`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*